These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19356116)

  • 21. Effect of R667, a novel emphysema agent, on the pharmacokinetics of midazolam in healthy men.
    Brennan BJ; Brown AB; Kolis SJ; Rutman O; Gooden C; Davies BE
    J Clin Pharmacol; 2006 Feb; 46(2):222-8. PubMed ID: 16432274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Context sensitive decrement times of remimazolam.
    Schnider T; Minto C
    Anesth Analg; 2013 Jul; 117(1):285. PubMed ID: 23788743
    [No Abstract]   [Full Text] [Related]  

  • 23. Remimazolam: new beginnings or just a me-too?
    Sneyd JR
    Anesth Analg; 2012 Aug; 115(2):217-9. PubMed ID: 22826518
    [No Abstract]   [Full Text] [Related]  

  • 24. Recirculatory pharmacokinetic modeling: what goes around, comes around.
    Krejcie TC; Avram MJ
    Anesth Analg; 2012 Aug; 115(2):223-6. PubMed ID: 22826520
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacokinetics and metabolism of oral midazolam in preterm infants.
    de Wildt SN; Kearns GL; Hop WC; Murry DJ; Abdel-Rahman SM; van den Anker JN
    Br J Clin Pharmacol; 2002 Apr; 53(4):390-2. PubMed ID: 11966671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New horizons in sedative hypnotic drug development: fast, clean, and soft.
    Johnson KB
    Anesth Analg; 2012 Aug; 115(2):220-2. PubMed ID: 22826519
    [No Abstract]   [Full Text] [Related]  

  • 27. Microsomal binding of amitriptyline: effect on estimation of enzyme kinetic parameters in vitro.
    Venkatakrishnan K; von Moltke LL; Obach RS; Greenblatt DJ
    J Pharmacol Exp Ther; 2000 May; 293(2):343-50. PubMed ID: 10773001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population pharmacokinetic modeling in very premature infants receiving midazolam during mechanical ventilation: midazolam neonatal pharmacokinetics.
    Lee TC; Charles BG; Harte GJ; Gray PH; Steer PA; Flenady VJ
    Anesthesiology; 1999 Feb; 90(2):451-7. PubMed ID: 9952152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of parecoxib, a parenteral cyclooxygenase-2 specific inhibitor, on the pharmacokinetics and clinical effects of midazolam.
    Ibrahim A; Karim A; Feldman J; Kharasch E
    Anesth Analg; 2002 Sep; 95(3):667-73, table of contents. PubMed ID: 12198057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the metabolism of midazolam in C57BL/6J and hepatic reductase null (HRN) mice.
    Grimsley A; Foster A; Gallagher R; Hutchison M; Lundqvist A; Pickup K; Wilson ID; Samuelsson K
    Biochem Pharmacol; 2014 Dec; 92(4):701-11. PubMed ID: 25450676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and metabolism of midazolam in chimeric mice with humanised livers.
    Samuelsson K; Pickup K; Sarda S; Swales JG; Morikawa Y; Schulz-Utermoehl T; Hutchison M; Wilson ID
    Xenobiotica; 2012 Nov; 42(11):1128-37. PubMed ID: 22642803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients.
    de Wildt SN; de Hoog M; Vinks AA; van der Giesen E; van den Anker JN
    Crit Care Med; 2003 Jul; 31(7):1952-8. PubMed ID: 12847388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mixed-effects modeling of the influence of midazolam on propofol pharmacokinetics.
    Vuyk J; Lichtenbelt BJ; Olofsen E; van Kleef JW; Dahan A
    Anesth Analg; 2009 May; 108(5):1522-30. PubMed ID: 19372331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma pharmacokinetics of midazolam in chickens, turkeys, pheasants and bobwhite quail.
    Cortright KA; Wetzlich SE; Craigmill AL
    J Vet Pharmacol Ther; 2007 Oct; 30(5):429-36. PubMed ID: 17803735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atmospheric pressure desorption/ionization on silicon ion trap mass spectrometry applied to the quantitation of midazolam in rat plasma and determination of midazolam 1'-hydroxylation kinetics in human liver microsomes.
    Steenwyk RC; Hutzler JM; Sams J; Shen Z; Siuzdak G
    Rapid Commun Mass Spectrom; 2006; 20(24):3717-22. PubMed ID: 17117443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Midazolam disposition in patients undergoing continuous venovenous hemodialysis.
    Bolon M; Bastien O; Flamens C; Paulus S; Boulieu R
    J Clin Pharmacol; 2001 Sep; 41(9):959-62. PubMed ID: 11549100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory Effect of Oxethazaine on Midazolam Metabolism in Rats.
    Namba H; Nishimura Y; Kurata N; Iwase M; Hirai T; Kiuchi Y
    Biol Pharm Bull; 2017; 40(9):1361-1365. PubMed ID: 28867721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral and plasma kinetics of a high dose of midazolam and correlations with its respiratory effects in rats.
    Megarbane B; Lesguillons N; Galliot-Guilley M; Borron SW; Trout H; Declèves X; Risède P; Monier C; Boschi G; Baud FJ
    Toxicol Lett; 2005 Oct; 159(1):22-31. PubMed ID: 15916873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cinacalcet does not affect the activity of cytochrome P450 3A enzymes, a metabolic pathway for common immunosuppressive agents : a randomized, open-label, crossover, single-centre study in healthy volunteers.
    Padhi D; Salfi M; Emery M
    Drugs R D; 2008; 9(5):335-43. PubMed ID: 18721002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absolute bioavailability of midazolam after subcutaneous administration to healthy volunteers.
    Pecking M; Montestruc F; Marquet P; Wodey E; Homery MC; Dostert P
    Br J Clin Pharmacol; 2002 Oct; 54(4):357-62. PubMed ID: 12392582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.